Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Amibegron

Generic Name: Amibegron

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₆ClNO_₄

CAS Number: 121524-08-1

Unique Ingredient Identifier: PDQ3ME68U3

Overview

Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility.

Background

Amibegron is an agonist for atypical beta3-adrenoceptors which inhibits intestinal motility.

Indication

Investigated for use/treatment in depression, irritable bowel syndrome (IBS), and obesity.

Associated Conditions

No associated conditions information available.

Clinical Trials

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Phase 3

Completed

Posted: 2009/03/04

Sponsor:Sanofi

ID:NCT00855530

Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine

Phase 3

Completed

Posted: 2009/01/19

Sponsor:Sanofi

ID:NCT00825058

Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine

Phase 3

Completed

Posted: 2009/01/19

Sponsor:Sanofi

ID:NCT00825019

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder

Phase 3

Terminated

Posted: 2007/09/26

Sponsor:Sanofi

ID:NCT00535340

Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

Phase 3

Completed

Posted: 2007/02/08

Sponsor:Sanofi

ID:NCT00432614

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy